The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases
Open accessAbstract
Summary: Background and objectives: The kidney is the organ most commonly involved in systemic amyloidosis. This study reports the largest clinicopathologic series of renal amyloidosis. Design, setting, participants, & measurements: This study provides characteristics of 474 renal amyloidosis cases evaluated at the Mayo Clinic Renal Pathology Laboratory from 2007 to 2011, including age, sex, serum creatinine, proteinuria, type of amyloid, and tissue distribution according to type. Results: The type of amyloid was Ig amyloidosis in 407 patients (85.9%), AA amyloidosis in 33 (7.0%), leukocyte chemotactic factor 2 amyloidosis in 13 (2.7%), fibrinogen A α chain amyloidosis in 6 (1.3%), Apo AI, Apo AII, or Apo AIV amyloidosis in 3 (0.6%), combined AA amyloidosis/Ig heavy and light chain amyloidosis in 1 (0.2%), and unclassified in 11 (2.3%). Laser microdissection/mass spectrometry, performed in 147 cases, was needed to determine the origin of amyloid in 74 of the 474 cases (16%), whereas immunofluorescence failed to diagnose 28 of 384 light chain amyloidosis cases (7.3%). Leukocyte chemotactic factor 2 amyloidosis and Apo AI, Apo AII, or Apo AIV amyloidosis were characterized by diffuse interstitial deposition, whereas fibrinogen A α chain amyloidosis showed obliterative glomerular involvement. Compared with other types, Ig amyloidosis was associated with lower serum creatinine, higher degree of proteinuria, and amyloid spicules. Conclusions: In the authors’ experience, the vast majority of renal amyloidosis cases are Ig derived. The newly identified leukocyte chemotactic factor 2 amyloidosis form was the most common of the rarer causes of renal amyloidosis. With the advent of laser microdissection/mass spectrometry for amyloid typing, the origin of renal amyloidosis can be determined in >97% of cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
ANDRADE, C. (1952) · Brain · doi:10.1093/brain/75.3.408 · Cited by 1,074
Vrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Self-citationHuman lysozyme gene mutations cause hereditary systemic amyloidosis
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., et al. (1993) · Nature · doi:10.1038/362553a0 · Cited by 657
Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain
Benson, M. D., Liepnieks, J., Uemichi, T., Wheeler, G., & Correa, R. (1993) · Nature Genetics · doi:10.1038/ng0393-252 · Cited by 219
Sethi, S., Gamez, J. D., Vrana, J. A., Theis, J. D., Robert Bergen, H., Zipfel, P. F., Dogan, A., & Smith, R. J. H. (2009) · Kidney International · doi:10.1038/ki.2008.657 · Cited by 200
Self-citationPurification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2
Yamagoe, S., Yamakawa, Y., Matsuo, Y., Minowada, J., Mizuno, S., & Suzuki, K. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02572-2 · Cited by 178
Leukocyte chemotactic factor 2: A novel renal amyloid protein
Benson, M. D., James, S., Scott, K., Liepnieks, J. J., & Kluve-Beckerman, B. (2008) · Kidney International · doi:10.1038/ki.2008.152 · Cited by 173
Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis
Gillmore, J. D., Lachmann, H. J., Rowczenio, D. M., Gilbertson, J. A., Zeng, C., Liu, Z.-H., Leishi, L., Wechalekar, A. D., & Hawkins, P. N. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060614 · Cited by 172
Benson, M. D., Liepnieks, J. J., Yazaki, M., Yamashita, T., Asl, K. H., Guenther, B. D., & Kluve‐Beckerman, B. (2001) · Genomics · doi:10.1006/geno.2000.6499 · Cited by 157
Cited by
Leung, N., Bridoux, F., Batuman, V., Chaidos, A., Cockwell, P., D’Agati, V. D., Dispenzieri, A., Fervenza, F. C., Fermand, J.-P., Gibbs, S., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0077-4 · Cited by 551
Self-citationDiagnosis of monoclonal gammopathy of renal significance
Bridoux, F., on behalf of the International Kidney and Monoclonal Gammopathy Research Group, Leung, N., Hutchison, C. A., Touchard, G., Sethi, S., Fermand, J.-P., Picken, M. M., Herrera, G. A., Kastritis, E., et al. (2015) · Kidney International · doi:10.1038/ki.2014.408 · Cited by 426
Self-citationSystemic amyloidosis from A (AA) to T (ATTR): a review
Muchtar, E., Dispenzieri, A., Magen, H., Grogan, M., Mauermann, M., McPhail, E. D., Kurtin, P. J., Leung, N., Buadi, F. K., Dingli, D., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13169 · Cited by 327
Self-citationThe Pathology of Amyloidosis in Classification: A Review
Picken, M. M. (2020) · Acta Haematologica · doi:10.1159/000506696 · Cited by 313
Metadata
- Authors
- Said, S. M., Sethi, S., Valeri, A. M., Leung, N., Cornell, L. D., Fidler, M. E., Herrera Hernandez, L., Vrana, J. A., Theis, J. D., Quint, P. S., Dogan, A., & Nasr, S. H.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2013-09
- Volume
- 8
- Issue
- 9
- Pages
- 1515-1523
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2111523640
- Cited by
- 284
- References
- 20
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases. https://app.cochat.ai/papers/10.2215/cjn.10491012
- The paper
- Said, S. M., Sethi, S., Valeri, A. M., Leung, N., Cornell, L. D., Fidler, M. E., Herrera Hernandez, L., Vrana, J. A., Theis, J. D., Quint, P. S., Dogan, A., & Nasr, S. H. (2013). Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.10491012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.